These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15830643)

  • 21. Prevention of colon cancer by low doses of celecoxib, a cyclooxygenase inhibitor, administered in diet rich in omega-3 polyunsaturated fatty acids.
    Reddy BS; Patlolla JM; Simi B; Wang SH; Rao CV
    Cancer Res; 2005 Sep; 65(17):8022-7. PubMed ID: 16140976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats.
    Márquez-Rosado L; Trejo-Solís MC; García-Cuéllar CM; Villa-Treviño S
    J Hepatol; 2005 Oct; 43(4):653-60. PubMed ID: 16023763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omega-3 fatty acid regulates inflammatory cytokine/mediator messenger RNA expression in Porphyromonas gingivalis-induced experimental periodontal disease.
    Kesavalu L; Bakthavatchalu V; Rahman MM; Su J; Raghu B; Dawson D; Fernandes G; Ebersole JL
    Oral Microbiol Immunol; 2007 Aug; 22(4):232-9. PubMed ID: 17600534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levels of leukotriene B4 in gingival crevicular fluid and gingival tissue in specific periodontal diseases.
    Emingil G; Cinarcik S; Baylas H; Coker I; Hüseyinov A
    J Periodontol; 2001 Aug; 72(8):1025-31. PubMed ID: 11525433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of platelet-activating factor in gingival crevicular fluid and gingival tissue in specific periodontal diseases.
    Emingil G; Cinarcik S; Baylas H; Hüseyinov A
    J Periodontol; 2001 Aug; 72(8):1032-7. PubMed ID: 11525434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension.
    Hermann M; Camici G; Fratton A; Hurlimann D; Tanner FC; Hellermann JP; Fiedler M; Thiery J; Neidhart M; Gay RE; Gay S; Lüscher TF; Ruschitzka F
    Circulation; 2003 Nov; 108(19):2308-11. PubMed ID: 14597594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
    Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
    Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats.
    Queiroz-Junior CM; Pacheco CM; Maltos KL; Caliari MV; Duarte ID; Francischi JN
    J Periodontal Res; 2009 Apr; 44(2):153-60. PubMed ID: 19210344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An experimental study on chemoprevention of esophageal adenocarcinoma by celecoxib, a selective cyclooxygenase-2 inhibitor].
    Zhang T; Su LW; Zhu YF; Lang HJ; Zhang F; Zhou YA; Liang XH; Wang YJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 May; 15(5):512-6. PubMed ID: 22648851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery.
    Sakai M; Tanebe K; Sasaki Y; Momma K; Yoneda S; Saito S
    Mol Hum Reprod; 2001 Jun; 7(6):595-602. PubMed ID: 11385116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
    Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
    Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer.
    Cerchietti LC; Navigante AH; Castro MA
    Nutr Cancer; 2007; 59(1):14-20. PubMed ID: 17927497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis.
    Chen X; Wang S; Wu N; Sood S; Wang P; Jin Z; Beer DG; Giordano TJ; Lin Y; Shih WC; Lubet RA; Yang CS
    Clin Cancer Res; 2004 Oct; 10(19):6703-9. PubMed ID: 15475461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of chronic celecoxib on testicular function in normal and lipopolysaccharide-treated rats.
    Winnall WR; Muir JA; Liew S; Hirst JJ; Meachem SJ; Hedger MP
    Int J Androl; 2009 Oct; 32(5):542-55. PubMed ID: 18522674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
    Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
    Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetic acid-induced colitis in normal and essential fatty acid deficient rats.
    Mascolo N; Izzo AA; Autore G; Maiello FM; Di Carlo G; Capasso F
    J Pharmacol Exp Ther; 1995 Jan; 272(1):469-75. PubMed ID: 7815363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor.
    Yoshino T; Kimoto A; Kobayashi S; Noguchi M; Fukunaga M; Hayashi A; Miyata K; Sasamata M
    Arzneimittelforschung; 2005; 55(7):394-402. PubMed ID: 16080279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix Metalloproteinases, Tissue Inhibitor of Matrix Metalloproteinase-1, and Laminin-5 γ2 Chain Immunolocalization in Gingival Tissue of Endotoxin-Induced Periodontitis in Rats: Effects of Low-Dose Doxycycline and Alendronate.
    Buduneli E; Vardar-Şengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
    J Periodontol; 2007 Jan; 78(1):127-134. PubMed ID: 29539192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug.
    Lee HM; Ciancio SG; Tüter G; Ryan ME; Komaroff E; Golub LM
    J Periodontol; 2004 Mar; 75(3):453-63. PubMed ID: 15088884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.